Cargando…
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
SIMPLE SUMMARY: The identification of novel therapeutic strategies for Colorectal Cancer (CRC) patients with BRAF mutations is mandatory, since most of the current treatments against this tumor type, including novel compounds, show limited efficacy. In this article, we describe upregulated proteins...
Autores principales: | Morafraile, Esther Cabañas, Saiz-Ladera, Cristina, Nieto-Jiménez, Cristina, Győrffy, Balázs, Nagy, Adam, Velasco, Guillermo, Pérez-Segura, Pedro, Ocaña, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047091/ https://www.ncbi.nlm.nih.gov/pubmed/36975409 http://dx.doi.org/10.3390/curroncol30030196 |
Ejemplares similares
-
Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates
por: Alcaraz-Sanabria, Ana, et al.
Publicado: (2022) -
Genomic mapping of copy number variations influencing immune response in breast cancer
por: López-Cade, Igor, et al.
Publicado: (2022) -
Clinical considerations for the design of PROTACs in cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2022) -
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities
por: Paniagua-Herranz, Lucía, et al.
Publicado: (2023) -
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation
por: Noblejas-López, María del Mar, et al.
Publicado: (2021)